Drugs / Perflutren Lipid Microcpheres
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT04721886 Background | Nov 2020 → Jul 2023 | breast carcinoma | Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Perflutren Lipid Microcpheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04721886 ↗ |
| Route | Intravenous | “receive perflutren lipid microspheres (Definity) intravenously (IV) over 15 minutes” NCT04721886 ↗ |